Kopp Investment Advisors »

Horizon Therapeutics shares owned by Kopp Investment Advisors

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Kopp Investment Advisors from 13F filings

Historical chart of Kopp Investment Advisors investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Kopp Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Kopp Investment Advisors

Quarter filed Position value Share count Share price at filing
2019-09-30 $2.8M 105k 27.23
2019-06-30 $3.9M 162k 24.06

More positions owned by Kopp Investment Advisors

NeoGenomics (NEO)
Insulet Corporation (PODD)
Twilio Inc cl a (TWLO)
Cypress Semiconductor Corporation
Vericel (VCEL)
Horizon Therapeutics
Upland Software (UPLD)
Five9 (FIVN)
Cyberark Software (CYBR)
Omnicell (OMCL)
AtriCure (ATRC)
MaxLinear (MXL)
Supernus Pharmaceuticals (SUPN)
Spdr S&p 500 Etf (SPY)
RTI Biologics

View all positions for Kopp Investment Advisors

Top funds holding Horizon Therapeutics

Huntington National Bank

View all funds holding Horizon Therapeutics